Welcome to LookChem.com Sign In|Join Free

CAS

  • or

169104-33-0

Post Buying Request

169104-33-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

169104-33-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 169104-33-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,1,0 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 169104-33:
(8*1)+(7*6)+(6*9)+(5*1)+(4*0)+(3*4)+(2*3)+(1*3)=130
130 % 10 = 0
So 169104-33-0 is a valid CAS Registry Number.

169104-33-0Relevant articles and documents

Unexpected Retroaldol-Aldol Reaction during O-Alkylation of Hydroxylated Vince Lactam Derivatives

Bengtsson, Christoffer,Wetzel, Alexander,Bergman, Joakim,Br?nalt, Jonas

, p. 708 - 714 (2016)

The unexpected retroaldol-aldol reaction during O-alkylation of a β-hydroxy lactam was found to be highly dependent on the temperature and shows a remarkable solvent effect. In DMF, O-alkylation is faster than retroaldol-aldol rearrangement giving exclusively products with retention of configuration. In THF, O-alkylation is slower than rearrangement, giving selectively products with inversion of stereochemistry. In DMSO, a retroaldol reaction followed by fast intramolecular proton transfer occurs to give the ring-opened aldehyde.

Fluorinated conformationally restricted γ-aminobutyric acid aminotransferase inhibitors

Lu, Hejun,Silverman, Richard B.

, p. 7404 - 7412 (2008/02/01)

On the basis of the structures of several potent inhibitor molecules for γ-aminobutryric acid aminotransferase (GABA-AT) that were previously reported, six modified fluorine-containing conformationally restricted analogues were designed, synthesized, and tested as GABA-AT inhibitors. The syntheses of all six molecules followed from a readily synthesized ketone intermediate. Three of the molecules were found to be irreversible inhibitors of GABA-AT with comparable or larger kinact/K1 values than that of vigabatrin, a clinically used antiepilepsy drug, and the other three were reversible inhibitors. A possible mechanism for inactivation by one of the inactivators is proposed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 169104-33-0